Institute of Biochemistry of Biologically Active Compounds

https://ibiochemistry.by/  
230030 Grodno, A. Tyzengauz Square, 7

Multivitamin drug "Neurovasotropin" for the prevention of complications of diabetes (microangiopathy, neuropathy)

COUNTRY OF ORIGIN

IDENTIFIER

BO4842

PUBLISHED

2022-03-03

LAST UPDATE

2022-03-06

DEADLINE

Linked profile in other language
Responsible
Summary
The Institute of Biochemistry of Biologically Active Compounds offers consumers a multivitamin drug "Neurovasotropin" for the prevention of complications of diabetes (microangiopathy, neuropathy) under a manufactoring agreement and is looking for partners interested in a distribution service agreement.
Description
The pronounced antioxidant properties of thiamine and its derivatives were revealed, which were used to develop a new drug "Neurovasotropin" based on lipoic acid, thiamine and pyridoxine. It has been established that pyridoxal phosphate to a lesser extent, and thiamine to a greater extent, potentiate the antioxidant activity of lipoic acid. The inhibition by thiamine and thiochrome of the generation of hydroxyl radicals in the Fenton reaction is a decisive argument in favor of their use with lipoic acid in oxidative stress. Thiamine is a stronger antioxidant than lipoic acid in terms of its inhibitory effect on tyrosyl radicals of tyrosine.

Developed on the basis of the author's concept of hormonal mediation of the action of vitamins [Vinogradov, 1999], the new anti-stress complex "Neurovasotropin" is more effective in the prevention and correction of complications of diabetes mellitus (microangiopathy, neuropathy, nephropathy) than foreign analogues.
Advantages and Innovations
On the model of alloxan diabetes in rats, the hypoglycemic, anti-stress, antioxidant effect of the drug was established. The drug "Neurovastropin" stabilizes the activity of the glutathione system, inhibits the processes of lipid peroxidation in rat tissues.
Stage of development
Already on the market
Funding source
State budged
Internal
IPR status
Exclusive rights
Secret know-how
Sector group
BioChemTech
Healthcare

Organization information

Type
R&D institution
Year established
1970
NACE keywords
Q.86.90 - Other human health activities
M.72.11 - Research and experimental development on biotechnology
M.72.19 - Other research and experimental development on natural sciences and engineering
M.74.90 - Other professional, scientific and technical activities n.e.c.
Turnover (in EUR)
1-10M
Already engaged in transnational cooperation
Yes
Additional comments
In the structural subdivisions of the institute, research is carried out in the field of vitaminology, the study of molecular mechanisms of regulation of metabolism in normal and pathological conditions, the biochemistry of alcohol and drug addiction, neurochemistry and pharmacology.

The main activities are as follows: conducting fundamental and applied research aimed at studying the mechanisms of pathogenesis of diseases of the liver, cardiovascular and endocrine systems, alcohol dependence, pathological conditions associated with a deficiency of essential micronutrients and the effects of stress, in order to develop methods for their prevention, diagnosis and therapy; development of new innovative medicines, vitamin preparations, dietary supplements, as well as the development of methods for the isolation and purification of biologically active compounds from herbal medicinal raw materials, the development of their laboratory production for the needs of the pharmaceutical industry.

The Institute has developed unique technologies for obtaining dry extracts from medicinal plant materials and spicy-aromatic plants for use as components:
- in the production of dietary supplements,
- in the food industry,
- in the production of perfumery.

Production under the order of products of deep processing and purification of extracts from vegetable raw materials for use as analytical standards is possible.
Languages spoken
English
Russian

Information about partnership

Type of partnership considered
Distribution services agreement
Manufacturing agreement
Type and role of partner sought
Consumers interested in purchasing the multivitamin drug "Neurovasotropin" for the prevention of complications of diabetes (microangiopathy, neuropathy) under a manufacturing agreement.

Distributors interested in purchasing a multivitamin drug "Neurovasotropin" for the prevention of complications of diabetes (microangiopathy, neuropathy) under a distribution services agreement.
Type and size of partner sought
251-500
SME 51-250
SME 11-50
SME <= 10
R&D Institution
University

Attachments

Views: 1080
Statistics since 03.03.2022 16:45:44